Vera Therapeutics, Inc.
VERA
$21.71
-$0.32-1.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -51.69M | -43.43M | -46.63M | -33.71M | -28.38M |
| Total Depreciation and Amortization | 85.00K | 55.00K | 24.00K | 1.50M | 11.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.64M | 4.92M | 3.86M | 1.29M | 3.16M |
| Change in Net Operating Assets | -9.44M | -728.00K | 5.86M | 6.14M | -8.62M |
| Cash from Operations | -54.41M | -39.18M | -36.89M | -24.78M | -33.83M |
| Capital Expenditure | -187.00K | -645.00K | -238.00K | -89.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 15.50M | -220.74M | 38.56M | -22.59M | -219.29M |
| Cash from Investing | 15.32M | -221.38M | 38.32M | -22.68M | -219.29M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.53M | 347.31M | 752.00K | 3.44M | 294.41M |
| Repurchase of Common Stock | -- | 0.00 | -13.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -21.36M | 0.00 | 0.00 | -17.87M |
| Cash from Financing | 1.53M | 325.96M | 739.00K | 3.44M | 276.54M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -37.56M | 65.39M | 2.17M | -44.02M | 23.42M |